Vimentin is at the heart of epithelial mesenchymal transition (EMT) mediated metastasis

S Usman, NH Waseem, TKN Nguyen, S Mohsin… - Cancers, 2021 - mdpi.com
Simple Summary Vimentin is an important filamentous protein providing structural and
functional support to the cell. During initial stages of cancer development, vimentin …

Role of EMT in metastasis and therapy resistance

BN Smith, NA Bhowmick - Journal of clinical medicine, 2016 - mdpi.com
Epithelial–mesenchymal transition (EMT) is a complex molecular program that regulates
changes in cell morphology and function during embryogenesis and tissue development …

Fibroblast growth factor signaling in skeletal development and disease

DM Ornitz, PJ Marie - Genes & development, 2015 - genesdev.cshlp.org
Fibroblast growth factor (FGF) signaling pathways are essential regulators of vertebrate
skeletal development. FGF signaling regulates development of the limb bud and formation of …

TGF-β-induced fibrosis: A review on the underlying mechanism and potential therapeutic strategies

CH Ong, CL Tham, HH Harith, N Firdaus… - European journal of …, 2021 - Elsevier
Transforming growth factor-beta (TGF-β) plays multiple homeostatic roles in the regulation of
inflammation, proliferation, differentiation and would healing of various tissues. Many studies …

Achondroplasia: Development, pathogenesis, and therapy

DM Ornitz, L Legeai‐Mallet - Developmental dynamics, 2017 - Wiley Online Library
Autosomal dominant mutations in fibroblast growth factor receptor 3 (FGFR3) cause
achondroplasia (Ach), the most common form of dwarfism in humans, and related …

[HTML][HTML] Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial–mesenchymal transition in cancer

NM Ghahhari, S Babashah - European journal of cancer, 2015 - Elsevier
The WNT/β-catenin signalling implies its significance in maintaining an epithelial cell
phenotype, proper cell–cell junctions, and tissue homeostasis. Dysregulation of the …

Epithelial–mesenchymal transition and its transcription factors

P Debnath, RS Huirem, P Dutta… - Bioscience …, 2022 - portlandpress.com
Epithelial–mesenchymal transition or EMT is an extremely dynamic process involved in
conversion of epithelial cells into mesenchymal cells, stimulated by an ensemble of …

Extracellular-signal regulated kinase: A central molecule driving epithelial–mesenchymal transition in cancer

M Olea-Flores, MD Zuñiga-Eulogio… - International journal of …, 2019 - mdpi.com
Epithelial–mesenchymal transition (EMT) is a reversible cellular process, characterized by
changes in gene expression and activation of proteins, favoring the trans-differentiation of …

SOX9 drives the epithelial–mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway

JQ Huang, FK Wei, XL Xu, SX Ye, JW Song… - Journal of translational …, 2019 - Springer
Background The distant metastasis of cancer cells is a risk factor for tumor lethality and poor
prognosis in non-small-cell lung carcinoma (NSCLC). Increased SOX9 expression has been …

[HTML][HTML] Biomarkers for EMT and MET in breast cancer: An update

F Liu, LN Gu, BE Shan, CZ Geng… - Oncology …, 2016 - spandidos-publications.com
Metastasis and recurrence are the leading cause of mortality due to breast cancer, but the
underlying mechanisms are still poorly understood. Understanding the breast cancer …